LP

Lisa Pendlebury

Hansen Technologies Limited | Non-Executive Director
Ms Pendlebury has more than 25 years of experience across a range of industries. She currently serves as the General Manager of Corporate Development at Regis Healthcare and has previously worked at Mayne Pharma, Pacific Brands, JPMorgan and CVC Capital Partners. Lisa has experience in mergers and acquisitions, corporate strategy, investor relations, financial reporting, corporate governance, remuneration and sustainability.

Company and Role

Company
Title
Tenure
Since
HSN
HSN
Hansen Technologies Limited
  • Non-Executive Director
4yrs, 4mthMar 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
HSN
HSN
Hansen Technologies Limited
30/06/25N/A19,584N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
HSN
HSN
Hansen Technologies Limited
21/02/25
Buy
5,715$5.252$30,017On-market trade
HSN
HSN
Hansen Technologies Limited
23/02/23
Buy
6,450$4.642$29,939On-market trade
HSN
HSN
Hansen Technologies Limited
21/03/22
Issued
100$5.120$512Dividend Reinvestment Plan (DRP)